Skip to main content
Download PDF

Long-term study of Borrelia and Babesia prevalence and co-infection in Ixodes ricinus and Dermacentor recticulatus ticks removed from humans in Poland, 2016–2019

Parasites & Vectors volume 14, Article number: 348 (2021) Cite this article

Abstract

Background

Lyme borreliosis (LB) is the most common vector-borne disease in Europe. Monitoring changes in the prevalence of different Borrelia species in ticks may be an important indicator of risk assessment and of differences in pathogenicity in humans. The objective of our study was to assess the prevalence, co-infection and distribution of Borrelia and Babesia species in ticks removed from humans in a large sample collected during a study period of 4 years.

Methods

The ticks were collected throughout Poland from March to November over 4-year period from 2016 to 2019. All ticks (n = 1953) were morphologically identified in terms of species and developmental stage. Molecular screening for Borrelia and Babesia by amplification of the flagellin gene (flaB) or 18S rRNA marker was performed. Pathogen identity was confirmed by Sanger sequencing or PCR–restriction fragment length polymorphism analysis.

Results

The ticks removed from humans in Poland during this study belonged to two species: Ixodes ricinus (97%) and Dermacentor reticulatus (3%). High Borrelia prevalence (25.3%), including B. miyamotoi (8.4%), was confirmed in Ixodes ricinus ticks removed from humans, as was the change in frequency of occurrence of Borrelia species during the 4-year study. Despite Babesia prevalence being relatively low (1.3%), the majority of tested isolates are considered to be pathogenic to humans. Babesia infection was observed more frequently among Borrelia-positive ticks (2.7%) than among ticks uninfected with Borrelia (0.8%). The most frequent dual co-infections were between Borrelia afzelii and Babesia microti. The presence of Borrelia was also confirmed in D. reticulatus (12.7%); however the role of these ticks in spirochete transmission to susceptible hosts is still unclear.

Conclusions

Although the overall risk of developing LB after a tick bite is low in Europe, knowledge of the prevalence and distribution of Borrelia and Babesia species in ticks might be an important indicator of the risk of both these tick-borne diseases.

Graphical abstract

Background

With 85,000 cases reported annually, Lyme borreliosis (LB) is the most common vector-borne disease in Europe [1]. The estimated incidence of LB in Poland increased dramatically from 20.3 per 100,000 inhabitants in 2007 to 53.6 per 100,000 inhabitants in 2019 (an estimated average increase from 7735 cases per year in 2007 to 20,614 cases per year in 2019) [2]. However, the reliability of current incidence data on LB is uncertain due to diagnostic problems and limited reporting [3]. At least five species of Borrelia, namely Borrelia burgdorferi (s.s.), B. garinii, B. afzelii, B. spielmanii and B. bavariensis, are known to be pathogenic to humans, with each of these species believed to be associated with different clinical manifestations. The heterogeneity among B. burgdorferi (s.l.) species seems to be the main factor causing the regional differences in the clinical expression of human LB [4]. Borrelia burgdorferi (s.s.) is believed to be arthritogenic, B. afzelii causes mainly skin infections and B. garinii is especially neurotropic. Recently, Borrelia miyamotoi has been identified as a human pathogen related to relapsing fever in Europe [5] and little is known about its local impact on human health. Borrelia miyamotoi disease (BMD) has also been confirmed in an immunocompetent patient, and BMD concurrent with Lyme disease has also been described [6].

In Europe, cases of human babesiosis is reported sporadically, with about 60 confirmed cases caused mainly by Babesia divergens described to date in several European countries, including France, UK, Austria, the Czech Republic, Finland, Germany, Italy, Portugal, Switzerland and Poland (for review, see [7]). Non-specific clinical symptoms of human babesiosis, such as fever, flu-like symptoms, headaches, chills, sweats and myalgia, as well as the diagnostic difficulties have a key impact on their correct diagnosis and, consequently, effective treatment [8]. Babesia microti infections in immunocompetent individuals often have an asymptomatic but chronic course [9]. In terms of safe blood donation, this is of fundamental importance, especially if blood recipients are immunosuppressed. Transfusion-transmitted babesiosis is being increasingly described globally, mainly in the USA [10].

The tick species Ixodes ricinus is associated with deciduous and mixed forests, but the increasing numbers of I. ricinus observed over the past decades have allowed it to extend its range to northern areas of the continent and areas located at a higher altitude [11]. Cull et al. [12] have shown that I. ricinus typically constitute 90–100% of all ticks removed from humans in Europe and that nymphs are the most commonly detected life stage associated with zoonotic pathogen transmission. The increase in the density of ticks, also in urban areas, and the prolonged period of activity of these arachnids are probably the result of changes occurring in the environment, such as in land use in agriculture, forest management, changes in abundance and distribution of free living animals and climate change [13,14,15,16]. The observed phenomena translate directly into an increase in the risk of transmission of pathogens vectored by ticks, which can be a significant health problem, especially for people with an impaired immune system, whose percentage in the general population is steadily increasing [17].

Ixodes ricinus ticks are competent vectors for many species of pathogenic viruses, bacteria and protozoa. An important problem in the epidemiology of tick-borne diseases is co-infection, i.e. simultaneous, multi-species infections; such infections are especially difficult to diagnose in humans [18]. Co-infection in humans and animals might enhance disease severity and may have significant consequences in terms of tick-borne disease treatment and diagnosis [18, 19].

Knowledge of Borrelia prevalence and species distribution is crucial to our understanding of the epidemiology as well as of the prevention and diagnosis of LB. There are only a limited number of studies on the prevalence of specific pathogenic species in ticks removed from humans, which mainly provided information on the B. burgdorferi (s.l.) complex. In Poland, most of the studies conducted to date were on questing ticks or ticks collected from animals [20,21,22,23,24,25,26,27]. However, the evaluation of pathogens in ticks parasitizing humans may provide specific information on the risk of human exposure to tick-borne infections. The aim of our study was to assess the prevalence and distribution of Borrelia and Babesia species in ticks removed from humans in Poland, in a large sample collected during a 4-year study period.

Methods

Tick collection and identification

The research reported here was conducted over 4-year period from 2016 to 2019. The ticks were collected throughout Poland from March to November of each year and then were delivered directly by patients or by a delivery company in a tightly-sealed, ethanol-filled container to the Diagnostic Laboratory of Parasitic Diseases and Zoonotic Infections AmerLab Ltd, a spin-off company of the University of Warsaw and Medical University of Warsaw, within 5 days after removal from the skin by a physician or the patients themselves. Ticks were morphologically identified in terms of species and developmental stage using a standard taxonomic key [28]. Specimens that could not be identified due to being extensively damaged when being removed from the skin were not included in the study.

DNA extraction and PCR analysis

Individual larvae, nymph and adult ticks were washed in sterile ethanol and then in sterile water to avoid DNA contamination and then homogenized using sterile a mini-homogenizer with hand-held mixing motor drive (EURx, Gdańsk, Poland). Genomic DNA from ticks was isolated using the DNeasy Blood & Tissue Kit (Qiagen, Hilden, Germany) according to the manufacturer’s protocol. Genomic DNA was used for molecular screening for spirochetes through amplification of the flagellin gene (flaB) marker, using the primers reported in [29]. Initial PCR conditions were modified as follows: 95 °C, 5 min (initial denaturation); then 95 °C/30 s (denaturation), 52 °C/30 s (primer annealing), 72 °C/80 s (elongation), for 35 cycles; and a final elongation at 72 °C for 7 min. Nested PCR was performed with minor modification: 95 °C, 20 s (denaturation); then 55 °C/20 s (denaturation), 72 °C/60 s (elongation). For B. miyamotoi detection among positive samples, specific primers for the flaB marker were used [24]. Babesia spp. were detected and identified using GR2 and GF2 primers targeting the 18S rDNA fragment. The primers and thermal profiles used in this study are described in [30]. Negative controls were performed in the absence of template DNA. Babesia microti King’s College strain DNA isolated from infected BALB/c mice blood and sequenced Borrelia DNA obtained from infected ticks [24] were used as positive controls. PCR products were visualized in 1.5% agarose gels stained with Midori Green Stain (Nippon Genetics Europe, Düren, Germany).

Identification of Borrelia and Babesia species

Borrelia-positive samples from ticks collected in 2016 and 2017 and Babesia-positive samples from ticks collected in 2016, 2017 and 2018 were sequenced by a private company (Genomed S.A., Warszawa, Poland) in both directions. Obtained nucleotide sequences were analyzed using BLAST NCBI and MEGA v. 7.0 software [31] for sequence alignment and species typing using sequences deposited in GenBank NCBI. The new nucleotide sequences have been deposited in the GenBank database under accession numbers MW791411–MW791420.

Restriction fragment length polymorphism (RFLP) was used to differentiate Borrelia-positive isolates at the species level obtained in 2018 and 2019. Positive amplicons after nested PCR were digested with the restriction enzyme HpyF3I (Thermo Fisher Scientific, Waltham, MA USA), which recognizes the 5′C↓TNAG3′ sequence [29], according to the manufacturer’s protocol. The digestion products were separated in a 2% agarose gel, visualized and archived in the GelDoc-It imaging system (Thermo Fisher Scientific). The obtained restriction patterns enabled recognition of species of the B. burgdorferi complex and B. miyamotoi.

Statistical analysis

Statistical analysis was performed using IBM SPSS Statistics v. 25.0 software (IBM Corp., Armonk, NY, USA). Prevalence of Borrelia and Babesia infection (percentage of ticks infected) was analyzed using maximum likelihood techniques based on log-linear analysis of contingency tables (HILOGLINEAR). For analysis of the prevalence of Borrelia and Babesia in ticks, we fitted the prevalence of pathogens as a binary factor (infected = 1, uninfected = 0) and then by year (4 levels: 2016–2019 for Borrelia; 3 levels: 2016–2018 for Babesia) and tick stadium (larvae, nymphs, adults). P values < 0.05 were considered to be statistically significant.

Results

Ixodes ricinus and D. reticulatus ticks

Almost all ticks collected from humans in during the study period (2016–2019) were I. ricinus (97%), with the other tick species identified being D. reticulatus (3%).

A total of 1890 I. ricinus ticks were collected from humans during the study period, of which 54 (2.9%) were larvae, 1298 (68.7%) were nymphs, 524 (27.7%) were females and 14 (0.7%) were males. Most of these ticks were collected in 2018–2019 (n = 762 and n = 775, respectively), whereas in 2016–2017 only 353 ticks were analyzed (n = 126 and n = 227, respectively). Two peaks of tick activity were observed: the first in June, followed by a second one in October; however, the mean number of ticks collected in October was almost fourfold lower than that in June (Fig. 1). The number of ticks in each stadium (larvae, nymphs and adults) removed from humans varied significantly between the months of study (month × number of I. ricinus ticks in each stadium: χ216 = 85.5, P < 0.000; Fig. 1; Additional File 1). Over the entire study period, the median number of larvae collected per month was six, with a minimum of two larvae (in May), a maximum of 18 larvae (in July) and no larvae collected in March–April and November. The highest number of nymphs (n = 413) and adults (n = 148) was noted in June, whereas the median number of ticks collected by month was 144 for nymphs and 60 for adults.

Fig. 1
figure 1

Total number of Ixodes ricinus ticks by stage and month collected during the 4 years of the study. Statistical differences between tick stages (larvae, nymphs, adults) and month of study (March–November): P < 0.000

Full size image

A total of 63 D. reticulatus ticks were collected from humans during the study period, of which 41 (65%) were females and 22 (35%) were males. Most D. reticulatus ticks were collected in 2018 and 2019 (n = 54; 85.7%). Over the entire study period, the median number of ticks collected monthly was seven; however, the highest number of ticks was noted from March to May (21 and 21, respectively; 30% of all collected ticks), and no D. reticulatus ticks were observed in July and August (month × number of D. reticulatus ticks in each stadium: χ28 = 14.8; P = 0.054) (Fig. 2; Additional File 2).

Fig. 2
figure 2

Total number of Dermacentor reticulatus ticks by stage and month collected during years of study. Statistical differences between tick stages (females, males) and month of study (March–November): P = 0.054

Full size image

Borrelia prevalence in I. ricinus and D. reticulatus ticks

Overall, the prevalence of Borrelia infection in the I. ricinus ticks removed from humans, as determined by nested PCR, was 25.3% (479/1890; CI: 23.4–27.3%) (Table 1). Statistical analysis of prevalence over the long term (i.e. the entire study period) revealed a significant decrease in Borrelia prevalence between 2016 (30.2%; CI: 22.7–38.6%) and 2019 (23.4%; CI: 20.5–26.4%) (χ23 = 7.58; P = 0.051; Table 1). A significant effect of tick stage was also observed (χ22 = 11.9; P = 0.003). Borrelia DNA was detected in 9.3% (5/54; CI: 3.6–19.1%) of Ixodes larvae, 24.7% (321/1298; CI: 22.5–27.2%) of Ixodes nymphs and 28.4% (153/538; CI: 24.7–32.3%) of adult Ixodes ticks (Table 1).

Table 1 Stadium and year distribution of Borrelia-infected ticks removed from humans between 2016 and 2019
Full size table

In total, 12.7% (8/63; CI: 6.1–22.2%) of the D. reticulatus ticks delivered to the laboratory during the 2016–2019 study period tested positive for Borrelia infections (Table 1). Prevalence of infection decreased from 20% (CI: 2.3–62.9%) in 2016 and 25% (CI: 2.8–71.6%) in 2017 to 7.7% (CI: 1.6–22.5%) in 2018 and 14.3% (CI: 5.0–30.5%) in 2019; however, only nine D. reticulatus ticks were tested within the first 2 years of the study (Table 1). Female ticks (9.8%; CI: 3.4–21.5%) were infected less often than males (18.2%; CI: 6.5–37.6%); however the differences between males and females were not statistically significant (P = 0.348).

Borrelia species in I. ricinus and D. reticulatus ticks

Species typing was conducted on the basis of sequencing of fragments of the flaB gene (540-bp product) or RFLP-PCR analysis. Species differentiation of Borrelia-infected ticks was successful in 251 of the 479 Borrelia-positive tick samples (52.4%) and, according to life stage, in 91 of 153 adults (59%), 157 of 321 nymphs (49%) and three of five larvae (60%). The most frequently detected Borrelia species was B. afzelii (65.3%; CI: 59.3–71.0%), followed by B. burgdorferi (10.8%; CI: 7.4–15.0%)), B. garinii (8.8%; CI: 5.7–12.7%), B. valaisiana (5.2%; CI: 2.9–8.4%), B. spielmanii (1.2%; CI: 0.3–3.2%) and B. lusitaniae (0.4%; CI: 0.0–1.8%) (Table 2). The spirochete B. miyamotoi, which causes relapsing fever, was identified in 8.4% (CI: 5.4–12.3%) of analyzed ticks.

Table 2 Borrelia species distribution in infected I. ricinus ticks (n = 251) removed from humans
Full size table

Borrelia species distribution showed no significant differences between tick stages (P = 0.231) (Table 2). Adult ticks were more frequently infected with B. afzelii (62.6%, 57/91; CI: 52.4–72.1%) and B. garinii (12.1%, 11/91; CI: 6.6–19.9%) than with other Borrelia species . In nymphs, the most commonly detected species were B. afzelii (66.9%, 105/157; CI: 59.3–73.9%) and B. burgdorferi (11.5%, 18/157; CI: 7.2–17.1%). Larvae were infected only with B. afzelii (66.7%, 2/3; CI: 17.7–96.1%) and B. lusitaniae (33.3%, 1/3; CI: 3.9–82.3%).

Species distribution in different sampling years is shown in Fig. 3 (χ218 = 49.9; P < 0.000; Additional File 3). Throughout our 4-year study, the collected ticks were predominantly infected with B. afzelii [60.5 (CI: 44.7–74.8%), 60.9 (CI: 48.7–72.2%), 77.9 (CI: 67.7–86.1%) and 58.3% (CI: 46.8–69.2%) in 2016, 2017, 2018 and 2019, respectively]. In 2016, B. miyamotoi was detected in 15.8% (CI: 6.9–29.7%) of ticks; in 2017 and 2018 the number of B. miyamotoi-infected ticks decreased to 3.1 (CI: 0.7–9.6%) and 6.5%, (CI: 2.5–13.6%) respectively; this was followed by an increase to 11.1% (CI: 5.4–19.9%) in 2019. Borrelia garinii was the second most frequently noted species in 2017 (23.4%; CI: 14.4–34.8%); however, only 1.3 (CI: 0.1–5.9%) and 4.2% (CI: 1.2–10.7%) ticks were infected in 2018 and 2019. Borrelia burgdorferi was the most frequently identified species after B. afzelii in 2018 and 2019 [9.1 (CI: 4.2–17.0%) and 20.8% (CI: 12.7–31.2%)]—despite only 3.1% (CI: 0.7–9.6%) of ticks being infected in 2017.

Fig. 3
figure 3

Prevalence of Borrelia burgdorferi species in I. ricinus ticks removed from humans according to study year (2016–2019). B. af Borrelia afzelii, B. ga B. garinii, B. bur B. burgdorferi, B. miy B. miyamotoi, B. val B. valaisiana, B. lus B. lusitaniae, B. sp B. spielmanii. Hierarchic logline analysis: year of study × Borrelia species prevalence: χ218 = 49.9; P < 0.000

Full size image

Analysis of co-infection in multiple infected ticks was performed only using RFLP-PCR in 2018 and 2019. Overall, 2.0% (3/149) of the analyzed I. ricinus ticks (two nymphs and female) carried two Borrelia species (B. afzelii with B. burgdorferi/B. miyamotoi/B. spielmanii), while triple infections were observed in only one (0.7%) female (B. afzelii/B. burgdorferi/B. lusitaniae) (Table 3).

Table 3 Co-infection in I. ricinus ticks removed from humans between 2016 and 2019
Full size table

Comparison of species distribution in I. ricinus ticks removed from humans with those from questing ticks in our previous study [24] showed that engorged ticks were by far more frequently infected with B. myiamotoi (P = 0.003), whereas questing ticks were more commonly infected with B. garinii (P = 0.0001). These results are shown in detail in Fig. 4.

Fig. 4
figure 4

Comparison of Borrelia species prevalence in I. ricinus ticks removed from humans between 2016 and 2019 (this study) and from questing ticks collected in our previous study [23]. Asterisks indicate statistically significant differences (P ≤ 0.05). See caption to Fig. 3 for species names

Full size image

Species differentiation of Borrelia-infected D. reticulatus ticks was successful in six of eight Borrelia-positive tick samples (75%). All Borrelia isolates were identified on the basis of RFLP-PCR analysis, as for B. afzelii.

Babesia prevalence in collected ticks

In total, 1.3% (15/1115; CI: 0.8–2.2%) of the I. ricinus ticks delivered to the laboratory during the study period tested positive for Babesia infections. No significant statistical differences between sex and stage of ticks and year of study were detected. The prevalence of Babesia infection ranged from 0.9% (2/227; CI: 0.2–2.8%) in 2017 to 2.4% (3/126; CI: 0.7–6.2%) in 2016. The higher Babesia prevalence of 2.4% (8/337; CI: 1.1–4.4%) was found in adult I. ricinus comparied to nymphs (0.9%, 7/737; CI: 0.4–1.9%); no infected larvae were noted (Additional File 4).

Species typing was performed on the basis of sequencing of 18S rRNA gene fragment (530-bp product); all positive PCR samples were sequenced. Alignment and BLAST-NCBI analyses revealed the presence of three Babesia species. Of the 15 isolates, nine (60%) showed a high similarity (> 99%) to the B. microti strain Jena isolated originally from a human patient in Germany (EF413181 [32]). The nucleotide sequences of five isolates (33.3%) were identical to B. venatorum isolated from human patients in Italy and Austria (AY046575 [33]). One isolate was identified as B. canis with a similarity level of > 99% to another Polish isolate (KT272401 [34]).

During 3 years of study (2016, 2017, 2018), one D. reticulatus tick (1/36, 2.8%) was infected with B. canis which showed a similarity level of > 99% to another Polish isolate (KT272401; [34]).

Borrelia and Babesia co-infection in I. ricinus ticks

Statistical analysis of co-infection in I. ricinus revealed significant differences among infected ticks (χ21 = 4.81; P = 0.028). Babesia-positive I. ricinus ticks were more frequently observed among Borrelia-positive ticks (2.7%; 8/290) than among ticks uninfected with Borrelia (0.8%; 7/810). The most frequent dual co-infections were between B. afzelii and B. microti (3/7), followed by B. afzelii and B. venatorum (2/7; Table 3).

Discussion

We performed a long-term study of Borrelia and Babesia prevalence in two tick species removed from humans in Poland. The results of this study may have important implications in terms of public health since the prevalence of B. burgdorferi (s.l.) spirochetes in ticks has been considered an essential element of risk assessment for LB [35].

The ticks collected in this study belonged to two species. While almost the whole of Europe is considered to be an endemic region for I. ricinus, the geographical range of D. reticulatus in Europe is discontinuous, with two main macroregions, and the spreading of D. reticulatus is believed to be associated with the loss of forest area [36]. The adult ticks collected in our study appeared to show a bimodal activity pattern, with the highest density in March–May and September–November, whereas no ticks were collected in the summer, which is typical for this tick species [37]. Dermacentor reticulatus represents the second genus of medical and veterinary importance after Ixodes in Europe. This tick species can bite humans [38] and is sporadically removed from patients in Germany, Belgium and Poland [39,40,41]. Several pathogens, including B. burgdorferi, have been detected in D. reticulatus ticks, suggesting a possible role of this tick species in the life-cycle and transmission of spirochetes, but it does not necessarily mean that they are capable of transmitting these bacteria to a susceptible host. Previous studies have shown that Borrelia prevalence in questing D. reticulatus ticks is significantly lower (by up to 4%) [34, 37, 42, 43] than that reported in our study. Nevertheless, the infection rates reported in engorged D. reticulatus ticks collected from dogs in a previous study [27] are similar to our results.

For I. ricinus, we observed peak activity in June, which is congruent with the results of our previous study on questing ticks [24] as well as with the results of other studies on the seasonality of I. ricinus bites on humans [12, 13, 44, 45]. The predominance of nymphs according to the month of the year observed in our study was similar to that found in other European studies on ticks collected from humans [39,40,41, 46,47,48]. We found that the activity of larvae was the highest in August and September; however, only 54 specimens in total were removed from humans. It is worth noting that the highest number of tick bites occurred during the summer period when people are more likely to be exposed to ticks by spending time outdoors, not only in natural areas.

Overall in Europe, including Poland, Borrelia prevalence in ticks removed from humans ranges from 5 to 29% [39,40,41, 46,47,48,49,50,51,52,53]. Surprisingly, between 2016 and 2019, annual Borrelia prevalence in ticks decreased significantly from 38 to 25%. At the same time, the number of LB cases in Poland decreased slightly from 21,220 in 2016 to 20,614 in 2019 [2]. Our previous studies have shown that annual Borrelia occurrence in questing I. ricinus ticks in Poland also varied from 8 to 15% between 2013 and 2014 [24]. These inter-annual fluctuations in Borrelia prevalence may be due to climatic or other ecological factors affecting tick density or the abundance and, as a result, the availability of reservoir hosts, such as rodents or birds. It has been proven that the relative abundance of the white-footed mouse (Peromyscus leucopus) is positively associated with the prevalence of nymphal infection, which is regarded as the most important indicator of LB risk [54]. Interestingly, the Borrelia prevalence in our study differed significantly between I. ricinus ticks removed from humans and questing ticks [24]. Some results from other studies suggest that the abundance of spirochaetes in questing Ixodes ticks may be low (< 300 copies of bacteria) and, therefore, often undetectable, while blood repletion or simply the increased ambient temperature triggers bacteria growth and increases detectability, but possibly only within a short period (around 72 h after changing the conditions) [55, 56]. Understanding of this phenomenon is limited at the present time.

The observed significant lower Borrelia infection rates in I. ricinus larvae compared to nymphs and in nymphs compared to adults is in accordance with previous studies on questing as well as engorged ticks [24, 25, 39, 41, 47]. Since each tick stadium has only one blood meal from different hosts and the probability of acquiring pathogens increase with every blood meal, the highest prevalence of infection is noted in adults ticks. It is believed that transovarial transmission of B. burgdorferi (s.l.) is rare or non-existent and seems not to be essential for the circulation of spirochetes in Europe [57]. However, van Duijvendijk et al. [58] showed that flagged larvae can transmit B. afzelii and B. miyamotoi to rodents. Compared to other Borrelia species, a significantly higher efficiency of transovarial transmission from infected females to 90% of their larvae has been noted for B. miyamotoi [59]. Thus, in our study, larvae infected mainly with B. miyamotoi were expected. However, detection of the spirochetes in larvae in both the present study and other studies [40, 48, 60] strengthens the body of evidence for transovarial transmission of Borrelia under field conditions. Nonetheless, Faulde et al. [50] did not confirm the case of acquired LB after the bite of an infected I. ricinus larva. Hence, the hypothesis of Borrelia transmission from larvae to human needs further experimental studies.

Since different Borrelia species are involved in specific clinical manifestations, it is crucial to have accurate numbers on the prevalence of a particular species in order to be able to make precise assessments. The identification of different Borrelia species in our study revealed that B. afzelii was the most frequent species within the study period; these results are comparable to data on questing and engorged ticks from other European countries (reviewed in [61]). The low frequency of B. spielmanii and B. lusitaniae could be explained by a relatively low abundance of the competent reservoir host for these species in Poland, mainly dormice (Eliomys quercinus, Muscardinus avellanarius) and lizards (Lacerta agilis) [62, 63]. Interestingly, in our study I. ricinus ticks removed from humans were more frequently infected with B. miyamotoi than was earlier reported for questing ticks [24], whereas the latter were significantly more often infected with B. garinii. We also observed that B. afzelii prevalence was higher in ticks removed from humans than in questing ticks. Similar results were obtained by Springer et al. [47] and Waindok et al. [39]. The differences in Borrelia prevalence in questing and engorged ticks might be the result of specific eco-epidemiological conditions within the habitats affecting the availability and abundance of reservoir hosts for ticks as well as for Borrelia spirochetes. Coipan et al. [64] also reported that B. afzelii and B. bavariensis were significantly more frequent in human cases than in questing ticks, which is related with the fact that both are rodent-associated Borrelia species. Rodents are the main reservoir hosts for these two Borrelia species, as well as for I. ricinus larvae and nymphs; therefore, this phenomenon might be the result of spatial overlap between habitats of rodents with areas of human activity where the risk of tick bites is significant [47, 64]. Nevertheless, no B. bavariensis isolates were observed in this study, likely due to using the single restriction enzyme DdeI, which is not able to distinguish the recently described B. bavariensis from B. garinii [21]. However, sequence analysis of Borrelia isolates collected in 2016 and 2017 did not confirm the presence of B. bavariensis species.

It is well-known that the distribution and prevalence of Borrelia spp. in questing and engorged ticks show significant temporal and spatial variations [10, 65] and that monitoring these changes might be an important indicator of risk assessment [66]. Surprisingly, in our study, the annual prevalence of B. miyamotoi was relatively high (up to 15.8% in 2016) compared to that reported in other European studies in questing as well as feeding ticks where the prevalence usually did not exceed 5–8% [24, 25, 47, 67,68,69,70]. Breuner et al. [70] showed that single I. scapularis nymphs effectively transmit B. miyamotoi while feeding and that transmission can occur within the first 24 h of nymphal attachment. Additionally, probably due to the overlap of endemic areas for B. miyamotoi with those for the B. burgdorferi (s.l.) complex, co-infections of B. miyamotoi with other spirochete species in I. ricinus ticks and humans have been observed [6, 24]. Taken together, these data indicate that the risk of B. myiamotoi infection in Poland should not be underestimated. So far, only one case of human B. miyamotoi infection has been diagnosed [71]. However, Fiecek et al. [71] suggested that in the case of the patients who do not meet the criteria for neuroboreliosis (presence of B. burgdorferi antibodies only in serum, no antibodies in polymyalgia rheumatica [PMR]), B. miyamotoi disease should be considered. According to the National Institute of Public Health–National Institute of Hygiene in Poland [2], in 2013 only 14% of all reported cases with neurological symptoms (n = 1267) met the clinical and laboratory criteria of neuroborreliosis (detection of antibodies in PMR) [71].

Co-infections in ticks are frequently reported, likely due to a large variety of animals from which they can ingest blood. Such co-infections may result in a combination of vertical (transovarial) and horizontal (blood meal) transmission of Borrelia species as well as a combination of systemic and co-feeding transmission [72]. Larval ticks taking multiple blood meals from different hosts (interrupted blood meals [59]) could also produce double infections of various host-specific species. The observed rate of co-infection prevalence in our study was significantly lower than that reported in feeding I. ricinus ticks in other European studies [39, 47]. Dual co-infection involving B. afzelii/B. burgdorferi or B. afzelii/B. miyamotoi were observed in nymphs, possibly a result of simultaneous infection during blood-feeding on rodents in the larval stadium. However, transovarial transmission of B. miyamotoi is also possible. Herrmann et al. [72] reported that Borrelia species which share the same vertebrate reservoir hosts frequently occur together and exhibit weak inhibition and even facilitation with respect to the spirochete load inside the nymphal tick. These authors also observed that rodents are relevant reservoir hosts for B. miyamotoi and B. afzelii, which explains the high number of double infections involving these two species. Alternatively, the co-occurrence of these two species in nymphs may be due to a combination of transovarial transmission of B. miyamotoi and horizontal transmission of B. afzelii [72].

Co-infections with B. afzelii/B. spielmanii and B. afzelii/B. burgdorferii/B. lusitaniae noted in I. ricinus females were likely the result of acquiring pathogens during successive blood meals on different reservoir hosts. Herrmann et al. [72] reported that B. burgdorferi (s.l.) species pairs that are specialized on different vertebrate reservoir hosts rarely occur together and that they exhibit strong inhibition with respect to spirochete load. This negative association between occurrence and spirochete load inhibition is likely caused by the vertebrate immune system (vertebrate complement system), which is present in the tick midgut and is capable of lysing spirochetes that are not adapted to that particular vertebrate host [72,73,74]. Nonetheless, the low prevalence of co-infection with different Borrelia species has suggested that the risk of this type co-infection in humans in Poland is low.

We found the prevalence of Babesia in the I. ricinus ticks removed from humans to be low and similar to that reported in other European studies on engorged as well as questing I. ricinus ticks [41, 75, 76]. In Europe, the majority of human babesiosis cases are caused by Babesia divergens [7]. However, in Poland so far only B. microti infections in humans have been noted [77,78,79,80]. Additionally, B. microti species occurred significantly more often than B. divergens in questing [81,82,83] and engorged (this study) I. ricinus ticks.

Recent studies concentrating on Babesia microti and Borrelia burgdorferi (s.s.) infections in rodents and ticks have indicated that co-infection with these pathogens is common in vectors and enzootic hosts, with a greater probability of co-infection than that predicted by chance, suggesting that co-infection provides a survival advantage to both pathogens; however, the molecular mechanism of these facilitation remain still unclear [18]. In our study, Babesia-positive I. ricinus ticks were observed significantly more often among Borrelia-positive ticks than among ticks not infected with Borrelia. However, it is difficult to conclude whether the observed findings are the result of positive interactions between these pathogens. Of the seven co-infections, three involved B. afzelii and B. microti, species that are associated with the same animal host (rodents); as such, the infections may have been acquired simultaneously, especially in nymphs. Diuk-Wasser et al. [18] discussed in their review that infection with Lyme spirochetes promotes the uptake of B. microti by ticks from the host (particularly reservoir host) and increases the suitability of the reservoir host for these parasites. Co-infections with other Borrelia/Babesia species in I. ricinus females are probably the consequences of sequential infection during feeding on various vertebrate hosts. Despite the fact that the Borrelia/Babesia species considered to be pathogenic for humans were involved in the majority of detected coinfections, its low prevalence suggests that the risk of this type of co-infection in humans in Poland is negligible.

Conclusions

In conclusion, our study confirms a relatively high Borrelia prevalence in ticks removed from humans, with the spirochete species showing a significant annual variation. Although based on detected sequences, B. afzelii constitutes the majority pathogenic species, the risk of B. miyamotoi disease in humans should not be underestimated. Analysis of Babesia prevalence suggests that the risk of human babesiosis is negligible, which is consistent with the low number of babesiosis cases reported in Poland. Although the overall risk of developing LB after a tick bite in Europe is 4% [84], increased knowledge of the prevalence and distribution of Borrelia and Babesia species in ticks may be an important indicator of both tick-borne disease risk assessment and varying pathogenicity in humans.

Availability of data and materials

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Lindgren E, Jaenson TGT. Lyme borreliosis in Europe. Influences of climate and climate change, epidemiology, ecology and adaptation measures. Copenhagen: World Health Organization; 2006. https://www.euro.who.int/__data/assets/pdf_file/0006/96819/E89522.pdf. Accessed Jan 2021

  2. National Institute of Public Health-National Institute of Hygiene. Epidemiological reports. https://www.pzh.gov.pl/serwisy-tematyczne/meldunki-epidemiologiczne/. Accessed Jan 2021

  3. Zajkowska J, Dunaj J. Lyme borreliosis. Challenges and difficulties of laboratory diagnosis. Forum Zakażeń. 2013;4(4):241–9.

    Article  Google Scholar 

  4. Margos G, Vollmer SA, Ogden NH, Fish D. Population genetics, taxonomy, phylogeny and evolution of Borrelia burgdorferi sensu lato. Infect Genet Evol. 2011;11(7):1545–63. https://doi.org/10.1016/j.meegid.2011.07.022.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Tobudic S, Burgmann H, Stanek G, Winkler S, Schötta AM, Obermüller M, et al. Human Borrelia miyamotoi infection, Austria. Emerg Infect Dis. 2020;26(9):2201–4. https://doi.org/10.3201/eid2609.191501.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Oda R, Kutsuna S, Sekikawa Y, Hongo I, Sato K, Ohnishi M, et al. The first case of imported Borrelia miyamotoi disease concurrent with Lyme disease. J Infect Chemother. 2017;23(5):333–5. https://doi.org/10.1016/j.jiac.2016.12.015.

    Article  PubMed  Google Scholar 

  7. Hildebrandt A, Gray JS, Hunfeld KP. Human babesiosis in Europe: what clinicians need to know. Infection. 2013;41(6):1057–72. https://doi.org/10.1007/s15010-013-0526-8.

    Article  CAS  PubMed  Google Scholar 

  8. Krause PJ. Human babesiosis. Int J Parasitol. 2019;49(2):165–74. https://doi.org/10.1016/j.ijpara.2018.11.007.

    Article  PubMed  Google Scholar 

  9. Bloch EM, Kumar S, Krause PJ. Persistence of Babesia microti infection in humans. Pathogens. 2019;8(3):102. https://doi.org/10.3390/pathogens8030102.

    Article  CAS  PubMed Central  Google Scholar 

  10. Ward SJ, Stramer SL, Szczepiorkowski ZM. Assessing the risk of Babesia to the United States blood supply using a risk-based decision-making approach: report of AABB’s Ad Hoc Babesia Policy Working Group (original report). Transfusion. 2018;58(8):1916–23. https://doi.org/10.1111/trf.14912.

    Article  PubMed  Google Scholar 

  11. Sormunen JJ, Kulha N, Klemola T, Mäkelä S, Vesilahti EM, Vesterinen EJ. Enhanced threat of tick-borne infections within cities? Assessing public health risks due to ticks in urban green spaces in Helsinki, Finland. Zoonoses Public Health. 2020;67(7):823–39. https://doi.org/10.1111/zph.12767.

  12. Cull B, Pietzsch ME, Gillingham EL, McGinley L, Medlock JM, Hansford KM. Seasonality and anatomical location of human tick bites in the United Kingdom. Zoonoses Public Health. 2020;67(2):112–21. https://doi.org/10.1111/zph.12659.

    Article  PubMed  Google Scholar 

  13. Buczek A, Ciura D, Bartosik K, Zając Z, Kulisz J. Threat of attacks of Ixodes ricinus ticks (Ixodida: Ixodidae) and Lyme borreliosis within urban heat islands in south-western Poland. Parasites Vectors. 2014;7:562. https://doi.org/10.1186/s13071-014-0562-y.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Léger E, Vourc’h G, Vial L, Chevillon C, McCoy KD. Changing distributions of ticks: causes and consequences. Exp Appl Acarol. 2013;59(1–2):219–44. https://doi.org/10.1007/s10493-012-9615-0.

    Article  PubMed  Google Scholar 

  15. Medlock JM, Hansford KM, Bormane A, Derdakova M, Estrada-Peña A, George JC, et al. Driving forces for changes in geographical distribution of Ixodes ricinus ticks in Europe. Parasit Vectors. 2013;6:1. https://doi.org/10.1186/1756-3305-6-1.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Pfäffle M, Littwin N, Muders SV, Petney TN. The ecology of tick-borne diseases. Int J Parasitol. 2013;43(12–13):1059–77. https://doi.org/10.1016/j.ijpara.2013.06.009.

    Article  PubMed  Google Scholar 

  17. Karp G, Schlaeffer F, Jotkowitz A, Riesenberg K. Syphilis and HIV co-infection. Eur J Intern Med. 2009;20:9–13. https://doi.org/10.1016/j.ejim.2008.04.002.

    Article  PubMed  Google Scholar 

  18. Diuk-Wasser MA, Vannier E, Krause PJ. Coinfection by Ixodes tick-borne pathogens: ecological, epidemiological, and clinical consequences. Trends Parasitol. 2016;32(1):30–42. https://doi.org/10.1016/j.pt.2015.09.008.

    Article  PubMed  Google Scholar 

  19. Krause PJ, Telford SR 3rd, Spielman A, Sikand V, Ryan R, Christianson D, et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA. 1996;275(21):1657–60.

    Article  CAS  PubMed  Google Scholar 

  20. Dunaj J, Zajkowska JM, Kondrusik M, Gern L, Rais O, Moniuszko A, et al. Borrelia burgdorferi genospecies detection by RLB hybridization in Ixodes ricinus ticks from different sites of North-Eastern Poland. Ann Agric Environ Med. 2014;21(2):239–43. https://doi.org/10.5604/1232-1966.1108583.

    Article  CAS  PubMed  Google Scholar 

  21. Kiewra D, Stańczak J, Richter M. Ixodes ricinus ticks (Acari, Ixodidae) as a vector of Borrelia burgdorferi sensu lato and Borrelia miyamotoi in Lower Silesia, Poland–preliminary study. Ticks Tick Borne Dis. 2014;5(6):892–7. https://doi.org/10.1016/j.ttbdis.2014.07.004.

    Article  PubMed  Google Scholar 

  22. Gryczyńska A, Welc-Falęciak R. Long-term study of the prevalence of Borrelia burgdorferi s.l. infection in ticks (Ixodes ricinus) feeding on blackbirds (Turdus merula) in NE Poland. Exp Appl Acarol. 2016;70(3):381–94. https://doi.org/10.1007/s10493-016-0082-x.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Wójcik-Fatla A, Zając V, Sawczyn A, Sroka J, Cisak E, Dutkiewicz J. Infections and mixed infections with the selected species of Borrelia burgdorferi sensu lato complex in Ixodes ricinus ticks collected in eastern Poland: a significant increase in the course of 5 years. Exp Appl Acarol. 2016;68(2):197–212. https://doi.org/10.1007/s10493-015-9990-4.

    Article  PubMed  Google Scholar 

  24. Kowalec M, Szewczyk T, Welc-Falęciak R, Siński E, Karbowiak G, Bajer A. Ticks and the city—are there any differences between city parks and natural forests in terms of tick abundance and prevalence of spirochaetes? Parasites Vectors. 2017;10(1):573. https://doi.org/10.1186/s13071-017-2391-2.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Kubiak K, Dziekońska-Rynko J, Szymańska H, Kubiak D, Dmitryjuk M, Dzika E. Questing Ixodes ricinus ticks (Acari, Ixodidae) as a vector of Borrelia burgdorferi sensu lato and Borrelia miyamotoi in an urban area of north-eastern Poland. Exp Appl Acarol. 2019;78(1):113–26. https://doi.org/10.1007/s10493-019-00379-z.

    Article  PubMed  Google Scholar 

  26. Michalik J, Wodecka B, Liberska J, Dabert M, Postawa T, Piksa K, et al. Diversity of Borrelia burgdorferi sensu lato species in Ixodes ticks (Acari: Ixodidae) associated with cave-dwelling bats from Poland and Romania. Ticks Tick Borne Dis. 2020;11(1): 101300. https://doi.org/10.1016/j.ttbdis.2019.101300.

    Article  PubMed  Google Scholar 

  27. Michalski MM, Kubiak K, Szczotko M, Chajęcka M, Dmitryjuk M. Molecular detection of Borrelia burgdorferi sensu lato and Anaplasma phagocytophilum in ticks collected from dogs in urban areas of North-Eastern Poland. Pathogens. 2020;9(6):455. https://doi.org/10.3390/pathogens9060455.

    Article  CAS  PubMed Central  Google Scholar 

  28. Hillyard PD. Ticks of North-West Europe. London: Backhuys Publishers; 1996.

    Google Scholar 

  29. Wodecka B. flaB gene as a molecular marker for distinct identification of Borrelia species in environmental samples by the PCR-restriction fragment length polymorphism method. Appl Environ Microbiol. 2011;77(19):7088–92. https://doi.org/10.1128/AEM.05437-11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Bonnet S, Jouglin M, L’Hostis M, Chauvin A. Babesia sp. EU1 from roe deer and transmission within Ixodes ricinus. Emerg Infect Dis. 2007;13(8):1208–10. https://doi.org/10.3201/eid1308.061560.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33(7):1870–4. https://doi.org/10.1093/molbev/msw054.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Hildebrandt A, Hunfeld KP, Baier M, Krumbholz A, Sachse S, Lorenzen T, et al. First confirmed autochthonous case of human Babesia microti infection in Europe. Eur J Clin Microbiol Infect Dis. 2007;26(8):595–601. https://doi.org/10.1007/s10096-007-0333-1.

    Article  CAS  PubMed  Google Scholar 

  33. Herwaldt BL, Cacciò S, Gherlinzoni F, Aspöck H, Slemenda SB, Piccaluga P, et al. Molecular characterization of a non-Babesia divergens organism causing zoonotic babesiosis in Europe. Emerg Infect Dis. 2003;9(8):942–8. https://doi.org/10.3201/eid0908.020748.

    Article  CAS  PubMed  Google Scholar 

  34. Mierzejewska EJ, Pawełczyk A, Radkowski M, Welc-Falęciak R, Bajer A. Pathogens vectored by the tick, Dermacentor reticulatus, in endemic regions and zones of expansion in Poland. Parasites Vectors. 2015;8:490. https://doi.org/10.1186/s13071-015-1099-4.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Rauter C, Hartung T. Prevalence of Borrelia burgdorferi sensu lato genospecies in Ixodes ricinus ticks in Europe: a metaanalysis. Appl Environ Microbiol. 2005;71(11):7203–16. https://doi.org/10.1128/AEM.71.11.7203-7216.2005.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Mierzejewska EJ, Estrada-Peña A, Bajer A. Spread of Dermacentor reticulatus is associated with the loss of forest area. Exp Appl Acarol. 2017;72(4):399–413. https://doi.org/10.1007/s10493-017-0160-8.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Kohn M, Krücken J, McKay-Demeler J, Pachnicke S, Krieger K, von Samson-Himmelstjerna G. Dermacentor reticulatus in Berlin/Brandenburg (Germany): activity patterns and associated pathogens. Ticks Tick Borne Dis. 2019;10(1):191–206. https://doi.org/10.1016/j.ttbdis.2018.10.003.

    Article  PubMed  Google Scholar 

  38. Estrada-Peña A, Jongejan F. Ticks feeding on humans: a review of records on human-biting Ixodoidea with special reference to pathogen transmission. Exp Appl Acarol. 1999;23(9):685–715. https://doi.org/10.1023/a:1006241108739.

    Article  PubMed  Google Scholar 

  39. Waindok P, Schicht S, Fingerle V, Strube C. Lyme borreliae prevalence and genospecies distribution in ticks removed from humans. Ticks Tick Borne Dis. 2017;8(5):709–14. https://doi.org/10.1016/j.ttbdis.2017.05.003.

    Article  PubMed  Google Scholar 

  40. Gałęziowska E, Rzymowska J, Najda N, Kołodziej P, Domżał-Drzewicka R, Rząca M, et al. Prevalence of Borrelia burgdorferi in ticks removed from skin of people and circumstances of being bitten—research from the area of Poland, 2012–2014. Ann Agric Environ Med. 2018;25(1):31–5. https://doi.org/10.5604/12321966.1233906.

    Article  PubMed  Google Scholar 

  41. Lernout T, De Regge N, Tersago K, Fonville M, Suin V, Sprong H. Prevalence of pathogens in ticks collected from humans through citizen science in Belgium. Parasites Vectors. 2019;12(1):550. https://doi.org/10.1186/s13071-019-3806-z.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Zając V, Wójcik-Fatla A, Sawczyn A, Cisak E, Sroka J, Kloc A, et al. Prevalence of infections and co-infections with 6 pathogens in Dermacentor reticulatus ticks collected in eastern Poland. Ann Agric Environ Med. 2017;24(1):26–32. https://doi.org/10.5604/12321966.1233893.

    Article  CAS  PubMed  Google Scholar 

  43. Dunaj J, Trzeszczkowski A, Moniuszko-Malinowska A, Rutkowski K, Pancewicz S. Assessment of tick-borne pathogens presence in Dermacentor reticulatus ticks in north-eastern Poland. Adv Med Sci. 2021;66(1):113–8. https://doi.org/10.1016/j.advms.2021.01.002.

    Article  PubMed  Google Scholar 

  44. Robertson JN, Gray JS, Stewart P. Tick bite and Lyme borreliosis risk at a recreational site in England. Eur J Epidemiol. 2000;16(7):647–52. https://doi.org/10.1023/a:1007615109273.

    Article  CAS  PubMed  Google Scholar 

  45. Wilhelmsson P, Lindblom P, Fryland L, Nyman D, Jaenson TG, Forsberg P, et al. Ixodes ricinus ticks removed from humans in Northern Europe: seasonal pattern of infestation, attachment sites and duration of feeding. Parasites Vectors. 2013;6:362. https://doi.org/10.1186/1756-3305-6-362.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Tijsse-Klasen E, Jacobs JJ, Swart A, Fonville M, Reimerink JH, Brandenburg AH, et al. Small risk of developing symptomatic tick-borne diseases following a tick bite in The Netherlands. Parasites Vectors. 2011;4:17. https://doi.org/10.1186/1756-3305-4-17.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Springer A, Raulf MK, Fingerle V, Strube C. Borrelia prevalence and species distribution in ticks removed from humans in Germany, 2013–2017. Ticks Tick Borne Dis. 2020;11(2):101363. https://doi.org/10.1016/j.ttbdis.2019.101363.

    Article  PubMed  Google Scholar 

  48. Kalmár Z, Dumitrache MO, D’Amico G, Matei IA, Ionică AM, Gherman CM, et al. Multiple tick-borne pathogens in Ixodes ricinus ticks collected from humans in Romania. Pathogens. 2020;9(5):390. https://doi.org/10.3390/pathogens9050390.

    Article  CAS  PubMed Central  Google Scholar 

  49. Fryland L, Wilhelmsson P, Lindgren PE, Nyman D, Ekerfelt C, Forsberg P. Low risk of developing Borrelia burgdorferi infection in the south-east of Sweden after being bitten by a Borrelia burgdorferi-infected tick. Int J Infect Dis. 2011;15(3):e174–81. https://doi.org/10.1016/j.ijid.2010.10.006.

    Article  PubMed  Google Scholar 

  50. Faulde MK, Rutenfranz M, Hepke J, Rogge M, Görner A, Keth A. Human tick infestation pattern, tick-bite rate, and associated Borrelia burgdorferi s.l. infection risk during occupational tick exposure at the Seedorf military training area, northwestern Germany. Ticks Tick Borne Dis. 2014;5(5):594–9. https://doi.org/10.1016/j.ttbdis.2014.04.009.

    Article  PubMed  Google Scholar 

  51. Jahfari S, Hofhuis A, Fonville M, van der Giessen J, van Pelt W, Sprong H. Molecular detection of tick-borne pathogens in humans with tick bites and erythema migrans, in the Netherlands. PLoS Negl Trop Dis. 2016;10(10):e0005042. https://doi.org/10.1371/journal.pntd.0005042.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Briciu VT, Flonta M, Ţăţulescu DF, Meyer F, Sebah D, Cârstina D, et al. Clinical and serological one-year follow-up of patients after the bite of Ixodes ricinus ticks infected with Borrelia burgdorferi sensu lato. Infect Dis (Lond). 2017;49(4):277–85. https://doi.org/10.1080/23744235.2016.1258488.

    Article  Google Scholar 

  53. Beltrame A, Laroche M, Degani M, Perandin F, Bisoffi Z, Raoult D, et al. Tick-borne pathogens in removed ticks Veneto, northeastern Italy: a cross-sectional investigation. Travel Med Infect Dis. 2018;26:58–61. https://doi.org/10.1016/j.tmaid.2018.08.008.

    Article  PubMed  Google Scholar 

  54. Vuong HB, Chiu GS, Smouse PE, Fonseca DM, Brisson D, Morin PJ, et al. Influences of host community characteristics on Borrelia burgdorferi infection prevalence in blacklegged ticks. PLoS ONE. 2017;12(1): e0167810. https://doi.org/10.1371/journal.pone.0167810.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Piesman J, Schneider BS, Zeidner NS. Use of quantitative PCR to measure density of Borrelia burgdorferi in the midgut and salivary glands of feeding tick vectors. J Clin Microbiol. 2001;39(11):4145–8. https://doi.org/10.1128/JCM.39.11.4145-4148.2001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Wilhelmsson P, Lindblom P, Fryland L, Ernerudh J, Forsberg P, Lindgren PE. Prevalence, diversity, and load of Borrelia species in ticks that have fed on humans in regions of Sweden and Åland Islands, Finland with different Lyme borreliosis incidences. PLoS ONE. 2013;8(11): e81433. https://doi.org/10.1371/journal.pone.0081433.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379(9814):461–73. https://doi.org/10.1016/S0140-6736(11)60103-7.

    Article  PubMed  Google Scholar 

  58. van Duijvendijk G, Coipan C, Wagemakers A, Fonville M, Ersöz J, Oei A, et al. Larvae of Ixodes ricinus transmit Borrelia afzelii and B. miyamotoi to vertebrate hosts. Parasites Vectors. 2016;9:97. https://doi.org/10.1186/s13071-016-1389-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Richter D, Debski A, Hubalek Z, Matuschka FR. Absence of Lyme disease spirochetes in larval Ixodes ricinus ticks. Vector Borne Zoonotic Dis. 2012;12(1):21–7. https://doi.org/10.1089/vbz.2011.0668.

    Article  PubMed  Google Scholar 

  60. Hauck D, Jordan D, Springer A, Schunack B, Pachnicke S, Fingerle V, et al. Transovarial transmission of Borrelia spp., Rickettsia spp. and Anaplasma phagocytophilum in Ixodes ricinus under field conditions extrapolated from DNA detection in questing larvae. Parasit Vectors. 2020;13(1):176. https://doi.org/10.1186/s13071-020-04049-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Rizzoli A, Hauffe H, Carpi G, Vourc HG, Neteler M, Rosa R. Lyme borreliosis in Europe. Euro Surveill. 2011;16(27):19906.

    Article  PubMed  Google Scholar 

  62. Ekner A, Dudek K, Sajkowska Z, Majláthová V, Majláth I, Tryjanowski P. Anaplasmataceae and Borrelia burgdorferi sensu lato in the sand lizard Lacerta agilis and co-infection of these bacteria in hosted Ixodes ricinus ticks. Parasites Vectors. 2011;4:182. https://doi.org/10.1186/1756-3305-4-182.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Richter D, Schlee DB, Matuschka FR. Reservoir competence of various rodents for the lyme disease Spirochete Borrelia spielmanii. Appl Environ Microbiol. 2011;77(11):3565–70. https://doi.org/10.1128/AEM.00022-11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Coipan EC, Jahfari S, Fonville M, Maassen CB, van der Giessen J, Takken W, et al. Spatiotemporal dynamics of emerging pathogens in questing Ixodes ricinus. Front Cell Infect Microbiol. 2013;3:36. https://doi.org/10.3389/fcimb.2013.00036.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Okeyo M, Hepner S, Rollins RE, Hartberger C, Straubinger RK, Marosevic D, et al. Longitudinal study of prevalence and spatio-temporal distribution of Borrelia burgdorferi sensu lato in ticks from three defined habitats in Latvia, 1999–2010. Environ Microbiol. 2020. https://doi.org/10.1111/1462-2920.15100.

    Article  PubMed  Google Scholar 

  66. Mechai S, Margos G, Feil EJ, Barairo N, Lindsay LR, Michel P, et al. Evidence for host-genotype associations of Borrelia burgdorferi sensu Stricto. PLoS ONE. 2016;11(2):e0149345. https://doi.org/10.1371/journal.pone.0149345.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Wilhelmsson P, Fryland L, Börjesson S, Nordgren J, Bergström S, Ernerudh J, et al. Prevalence and diversity of Borrelia species in ticks that have bitten humans in Sweden. J Clin Microbiol. 2010;48(11):4169–76. https://doi.org/10.1128/JCM.01061-10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Nunes M, Parreira R, Lopes N, Maia C, Carreira T, Sousa C, et al. Molecular Identification of Borrelia miyamotoi in Ixodes ricinus from Portugal. Vector Borne Zoonotic Dis. 2015;15(8):515–7. https://doi.org/10.1089/vbz.2014.1765.

    Article  PubMed  Google Scholar 

  69. Răileanu C, Tauchmann O, Vasić A, Wöhnke E, Silaghi C. Borrelia miyamotoi and Borrelia burgdorferi (sensu lato) identification and survey of tick-borne encephalitis virus in ticks from north-eastern Germany. Parasites Vectors. 2020;13(1):106. https://doi.org/10.1186/s13071-020-3969-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Breuner NE, Dolan MC, Replogle AJ, Sexton C, Hojgaard A, Boegler KA, et al. Transmission of Borrelia miyamotoi sensu lato relapsing fever group spirochetes in relation to duration of attachment by Ixodes scapularis nymphs. Ticks Tick Borne Dis. 2017;8(5):677–81. https://doi.org/10.1016/j.ttbdis.2017.03.008.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Fiecek B, Chmielewski T, Tylewska-Wierzbanowska S. Borrelia miyamotoi—new etiologic agent of neuroborreliosis? Przegl Epidemiol. 2017;71(4):531–8.

    PubMed  Google Scholar 

  72. Herrmann C, Gern L, Voordouw MJ. Species co-occurrence patterns among Lyme borreliosis pathogens in the tick vector Ixodes ricinus. Appl Environ Microbiol. 2013;79(23):7273–80. https://doi.org/10.1128/AEM.02158-13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  73. Kurtenbach K, Sewell HS, Ogden NH, Randolph SE, Nuttall PA. Serum complement sensitivity as a key factor in Lyme disease ecology. Infect Immun. 1998;66(3):1248–51. https://doi.org/10.1128/IAI.66.3.1248-1251.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Kurtenbach K, De Michelis S, Etti S, Schäfer SM, Sewell HS, Brade V, et al. Host association of Borrelia burgdorferi sensu lato—the key role of host complement. Trends Microbiol. 2002;10(2):74–9. https://doi.org/10.1016/s0966-842x(01)02298-3.

    Article  CAS  PubMed  Google Scholar 

  75. Lejal E, Marsot M, Chalvet-Monfray K, Cosson JF, Moutailler S, Vayssier-Taussat M, et al. A three-years assessment of Ixodes ricinus-borne pathogens in a French peri-urban forest. Parasites Vectors. 2019;12(1):551. https://doi.org/10.1186/s13071-019-3799-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Wilhelmsson P, Lövmar M, Krogfelt KA, Nielsen HV, Forsberg P, Lindgren PE. Clinical/serological outcome in humans bitten by Babesia species positive Ixodes ricinus ticks in Sweden and on the Åland Islands. Ticks Tick Borne Dis. 2020;11(4):101455. https://doi.org/10.1016/j.ttbdis.2020.101455.

    Article  CAS  PubMed  Google Scholar 

  77. Moniuszko A, Dunaj J, Swięcicka I, Zambrowski G, Chmielewska-Badora J, Zukiewicz-Sobczak W, et al. Co-infections with Borrelia species, Anaplasma phagocytophilum and Babesia spp. in patients with tick-borne encephalitis. Eur J Clin Microbiol Infect Dis. 2014;33(10):1835–41. https://doi.org/10.1007/s10096-014-2134-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Welc-Falęciak R, Pawełczyk A, Radkowski M, Pancewicz SA, Zajkowska J, Siński E. First report of two asymptomatic cases of human infection with Babesia microti (Franca, 1910) in Poland. Ann Agric Environ Med. 2015;22(1):51–4. https://doi.org/10.5604/12321966.1141394.

    Article  PubMed  Google Scholar 

  79. Moniuszko-Malinowska A, Swiecicka I, Dunaj J, Zajkowska J, Czupryna P, Zambrowski G, et al. Infection with Babesia microti in humans with non-specific symptoms in North East Poland. Infect Dis (Lond). 2016;48(7):537–43. https://doi.org/10.3109/23744235.2016.1164339.

    Article  Google Scholar 

  80. Dunaj J, Moniuszko-Malinowska A, Swiecicka I, Andersson M, Czupryna P, Rutkowski K, et al. Tick-borne infections and co-infections in patients with non-specific symptoms in Poland. Adv Med Sci. 2018;63(1):167–72. https://doi.org/10.1016/j.advms.2017.09.004.

    Article  PubMed  Google Scholar 

  81. Skotarczak B, Cichocka A. Isolation and amplification by polymerase chain reaction DNA of Babesia microti and Babesia divergens in ticks in Poland. Ann Agric Environ Med. 2001;8(2):187–9.

    CAS  PubMed  Google Scholar 

  82. Welc-Falęciak R, Bajer A, Paziewska-Harris A, Baumann-Popczyk A, Siński E. Diversity of Babesia in Ixodes ricinus ticks in Poland. Adv Med Sci. 2012;57(2):364–9. https://doi.org/10.2478/v10039-012-0023-9.

    Article  PubMed  Google Scholar 

  83. Wójcik-Fatla A, Zając V, Sawczyn A, Cisak E, Dutkiewicz J. Babesia spp. in questing ticks from eastern Poland: prevalence and species diversity. Parasitol Res. 2015;114(8):3111–6. https://doi.org/10.1007/s00436-015-4529-5.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Hofhuis A, van de Kassteele J, Sprong H, van den Wijngaard CC, Harms MG, Fonville M, et al. Predicting the risk of Lyme borreliosis after a tick bite, using a structural equation model. PLoS ONE. 2017. https://doi.org/10.1371/journal.pone.0181807.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Special thanks to Dorota Kiewra for her valuable comments and suggestions and to Magdalena Szatan and Maciej Kowalec for their technical support in DNA isolation and PCR amplification in Laboratory AmerLab Ltd.

Funding

Not applicable.

Author information

Authors and Affiliations

  1. Department of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, 3C Pawińskiego Street, 02-106, Warsaw, Poland

    Agnieszka Pawełczyk

  2. Department of Parasitology, Faculty of Biology, University of Warsaw, 1 Miecznikowa Street, 02-096, Warsaw, Poland

    Małgorzata Bednarska, Adrianna Hamera, Emilia Religa, Milena Poryszewska & Renata Welc-Falęciak

  3. Wild Urban Evolution and Ecology Lab, Centre of New Technologies, Banacha 2c Street, 02-097, Warsaw, Poland

    Ewa J. Mierzejewska

Authors
  1. Agnieszka Pawełczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Małgorzata Bednarska
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Adrianna Hamera
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Emilia Religa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Milena Poryszewska
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ewa J. Mierzejewska
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Renata Welc-Falęciak
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AP: analysis and interpretation of data, writing—original draft, review & editing. AP, MB, AH, MP, ER and EM: methodology (tick collection and molecular analysis), visualization, analysis and interpretation of data; RWF: conceptualization, analysis and interpretation of data, statistical analysis, supervision, writing—original draft, review & editing. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Renata Welc-Falęciak.

Ethics declarations

Ethics approval and consent to participate

The Internal Review Board of the Warsaw Medical University was informed about the study protocol (no. AKBE/73/2021). Informed consent was obtained from all individual participants included in the study in accordance with the Polish regulations. All experimental protocols were approved by Diagnostic Laboratory of Parasitic Diseases and Zoonotic Infections AmerLab Ltd, registered as medical entity in the National Chamber of Laboratory Diagnosticians (Poland).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1

: The number of I. ricinus ticks by stage, month and year collected during four years of study.

Additional file 2

: The number of D.reticulatus ticks by stage, month and year collected during the 4 years of the study

Additional file 3

: Borrelia genospecies/species distribution in infected I. ricinus ticks (n = 251) removed from humans between 2016 and 2019.

Additional file 4

: Stadium and year distribution of Babesia-infected I. ricinus ticks removed from humans in 2016, 2017 and 2018.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pawełczyk, A., Bednarska, M., Hamera, A. et al. Long-term study of Borrelia and Babesia prevalence and co-infection in Ixodes ricinus and Dermacentor recticulatus ticks removed from humans in Poland, 2016–2019. Parasites Vectors 14, 348 (2021). https://doi.org/10.1186/s13071-021-04849-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13071-021-04849-5

Keywords

  • Lyme borreliosis
  • Babesiosis
  • Co-infection
  • Ticks
  • Tick-borne diseases
  • Borrelia
  • Babesia

Parasites & Vectors

ISSN: 1756-3305

Contact us